CORD-19:932bcdd2f6c6d487386e8bf983e4874387771be1 / 125628-125825 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"T40384","span":{"begin":0,"end":197},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"We recently demonstrated the capacity of antiganglioside IgG to induce leukocyte activation via crosslinking of IgG receptors (FcgammaR), suggesting inflammatory potential of autoantibodies in GBS."}

    Epistemic_Statements

    {"project":"Epistemic_Statements","denotations":[{"id":"T285","span":{"begin":0,"end":197},"obj":"Epistemic_statement"}],"text":"We recently demonstrated the capacity of antiganglioside IgG to induce leukocyte activation via crosslinking of IgG receptors (FcgammaR), suggesting inflammatory potential of autoantibodies in GBS."}

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T262","span":{"begin":0,"end":197},"obj":"Sentence"}],"text":"We recently demonstrated the capacity of antiganglioside IgG to induce leukocyte activation via crosslinking of IgG receptors (FcgammaR), suggesting inflammatory potential of autoantibodies in GBS."}

    CORD-19-PD-MONDO

    {"project":"CORD-19-PD-MONDO","denotations":[{"id":"T625","span":{"begin":193,"end":196},"obj":"Disease"},{"id":"T88269","span":{"begin":193,"end":196},"obj":"Disease"}],"attributes":[{"id":"A625","pred":"mondo_id","subj":"T625","obj":"http://purl.obolibrary.org/obo/MONDO_0016218"},{"id":"A45930","pred":"mondo_id","subj":"T88269","obj":"http://purl.obolibrary.org/obo/MONDO_0016218"}],"text":"We recently demonstrated the capacity of antiganglioside IgG to induce leukocyte activation via crosslinking of IgG receptors (FcgammaR), suggesting inflammatory potential of autoantibodies in GBS."}